Christoph U. Correll, MD
Christoph U. Correll, MD
Hofstra North Shore LIJ School of Medicine and The Zucker Hillside Hospital
- Advisory Board: Eli Lilly and Company; Genentech, Inc.; Hoffmann-La Roche Inc.; Intra-Cellular Therapies, Inc.; Lundbeck Inc; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.
- Consultant: Eli Lilly and Company; Genentech, Inc.; Gerson Lehrman Group; Hoffmann-La Roche Inc.; Intra-Cellular Therapies, Inc.; Janssen-Cilag Pty Limited; Johnson & Johnson Services, Inc.; Lundbeck Inc; Medavante Inc; Medscape; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; ProPhase Labs, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.
- Grant Support: Novo Nordisk A/S
- Research Support: Bristol-Myers Squibb; Otsuka America Pharmaceutical, Inc.